Research ArticleClinical Studies
Fertility-sparing Management of Grade 2 and 3 Endometrial Adenocarcinomas
MARTIN KOSKAS, CHADI YAZBECK, FRANCINE WALKER, ELODIE CLOUQUEUR, AUBERT AGOSTINI, SANDRINE RUAT, JEAN PHILIPPE LUCOT, ERIC LAMBAUDIE, DOMINIQUE LUTON and PATRICK MADELENAT
Anticancer Research September 2011, 31 (9) 3047-3049;
MARTIN KOSKAS
CHADI YAZBECK
FRANCINE WALKER
ELODIE CLOUQUEUR
AUBERT AGOSTINI
SANDRINE RUAT
JEAN PHILIPPE LUCOT
ERIC LAMBAUDIE
DOMINIQUE LUTON
In this issue
Anticancer Research
Vol. 31, Issue 9
September 2011
Fertility-sparing Management of Grade 2 and 3 Endometrial Adenocarcinomas
MARTIN KOSKAS, CHADI YAZBECK, FRANCINE WALKER, ELODIE CLOUQUEUR, AUBERT AGOSTINI, SANDRINE RUAT, JEAN PHILIPPE LUCOT, ERIC LAMBAUDIE, DOMINIQUE LUTON, PATRICK MADELENAT
Anticancer Research Sep 2011, 31 (9) 3047-3049;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Pregnancy and oncologic outcomes after fertility-sparing management for early stage endometrioid endometrial cancer
- Cancer Incidence in Patients with Atypical Endometrial Hyperplasia Managed by Primary Hysterectomy or Fertility-sparing Treatment
- Progestins in the Fertility-Sparing Treatment and Retreatment of Patients With Primary and Recurrent Endometrial Cancer
- Progestin Treatment of Atypical Hyperplasia and Well-differentiated Adenocarcinoma of the Endometrium to Preserve Fertility